UBS Group’s VirnetX Holding Corp VHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.2K Sell
2,851
-5,098
-64% -$90.5K ﹤0.01% 7517
2025
Q4
$133K Buy
7,949
+5,128
+182% +$103K ﹤0.01% 6768
2025
Q3
$50.8K Sell
2,821
-4,523
-62% -$72.2K ﹤0.01% 7555
2025
Q2
$79.7K Sell
7,344
-6,867
-48% -$59.3K ﹤0.01% 7412
2025
Q1
$105K Sell
14,211
-8,487
-37% -$72.5K ﹤0.01% 7017
2024
Q4
$178K Buy
22,698
+17,527
+339% +$102K ﹤0.01% 6519
2024
Q3
$36.5K Buy
5,171
+4,239
+455% +$28.1K ﹤0.01% 7027
2024
Q2
$6.34K Buy
932
+296
+47% +$1.5K ﹤0.01% 7926
2024
Q1
$4.03K Sell
636
-1,533
-71% -$9.95K ﹤0.01% 7670
2023
Q4
$15.2K Buy
2,169
+829
+62% +$5.3K ﹤0.01% 7265
2023
Q3
$6.81K Buy
1,340
+533
+66% +$4.12K ﹤0.01% 7270
2023
Q2
$7.51K Buy
807
+87
+12% +$1.07K ﹤0.01% 7286
2023
Q1
$18.9K Sell
720
-476
-40% -$15.4K ﹤0.01% 7126
2022
Q4
$31.1K Buy
1,196
+126
+12% +$3.12K ﹤0.01% 7208
2022
Q3
$25K Buy
1,070
+125
+13% +$4.03K ﹤0.01% 7111
2022
Q2
$22K Sell
945
-5,908
-86% -$165K ﹤0.01% 6775
2022
Q1
$224K Sell
6,853
-794
-10% -$32.4K ﹤0.01% 5268
2021
Q4
$398K Buy
7,647
+844
+12% +$58.6K ﹤0.01% 5168
2021
Q3
$533K Sell
6,803
-148
-2% -$12.1K ﹤0.01% 4693
2021
Q2
$593K Sell
6,951
-1,105
-14% -$104K ﹤0.01% 4601
2021
Q1
$898K Buy
8,056
+6,337
+369% +$794K ﹤0.01% 4368
2020
Q4
$173K Buy
1,719
+919
+115% +$99.3K ﹤0.01% 5325
2020
Q3
$84K Sell
800
-1,196
-60% -$128K ﹤0.01% 5286
2020
Q2
$259K Sell
1,996
-1,177
-37% -$144K ﹤0.01% 4622
2020
Q1
$347K Sell
3,173
-1,276
-29% -$121K ﹤0.01% 4292
2019
Q4
$338K Buy
4,449
+1,383
+45% +$139K ﹤0.01% 5189
2019
Q3
$332K Buy
3,066
+2,458
+404% +$293K ﹤0.01% 4877
2019
Q2
$76K Sell
608
-265
-30% -$33.1K ﹤0.01% 5585
2019
Q1
$111K Sell
873
-927
-52% -$96.1K ﹤0.01% 4996
2018
Q4
$87K Buy
1,800
+262
+17% +$17.8K ﹤0.01% 5648
2018
Q3
$143K Buy
1,538
+243
+19% +$16.5K ﹤0.01% 5293
2018
Q2
$88K Buy
1,295
+419
+48% +$27.3K ﹤0.01% 5546
2018
Q1
$69K Sell
876
-188
-18% -$14.2K ﹤0.01% 5486
2017
Q4
$79K Sell
1,064
-30
-3% -$2.92K ﹤0.01% 5531
2017
Q3
$85K Buy
1,094
+878
+406% +$68.9K ﹤0.01% 5416
2017
Q2
$20K Sell
216
-71
-25% -$5.15K ﹤0.01% 6305
2017
Q1
$13K Sell
287
-387
-57% -$17.8K ﹤0.01% 6465
2016
Q4
$30K Sell
674
-287
-30% -$17.9K ﹤0.01% 6237
2016
Q3
$59K Buy
961
+416
+76% +$26.1K ﹤0.01% 5372
2016
Q2
$44K Buy
545
+2
+0.4% +$183 ﹤0.01% 5613
2016
Q1
$50K Sell
543
-281
-34% -$26K ﹤0.01% 5517
2015
Q4
$42K Buy
824
+148
+22% +$9.71K ﹤0.01% 5979
2015
Q3
$48K Sell
676
-382
-36% -$30.4K ﹤0.01% 5886
2015
Q2
$88K Sell
1,058
-32
-3% -$3.68K ﹤0.01% 5512
2015
Q1
$132K Sell
1,090
-1,075
-50% -$128K ﹤0.01% 5207
2014
Q4
$238K Buy
+2,165
New +$224K ﹤0.01% 4874

Other funds holding VHC

UBS Group's VHC Position: Q1 2026 in Review

UBS Group reduced its VirnetX Holding Corp (VHC) stake by 64% in Q1 2026, selling an estimated $90.5K and leaving 2,851 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7517.

UBS Group first reported a position in VHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $898K in Q1 2021. 29 funds tracked by Wall St. Rank hold VHC as of Q1 2026.

  • UBS Group held 2,851 shares of VirnetX Holding Corp worth $40.2K as of Q1 2026.
  • UBS Group sold 5,098 VirnetX Holding Corp shares in Q1 2026, an estimated $90.5K.
  • VirnetX Holding Corp made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7517 holding.
  • UBS Group first reported a position in VirnetX Holding Corp in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's VirnetX Holding Corp position peaked at $898K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held VirnetX Holding Corp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.